IoMT and telehealth APIs: the exposure surface that grew faster than anyone could inventory

Healthcare operations added, in just a few years, two entire categories of digital surface that barely existed at this scale before: networked medical devices — infusion pumps, monitors, imaging equipment — and telehealth platforms with APIs wired into insurance, pharmacy, medical records, and scheduling systems.

That expansion happened fast, usually faster than the ability to inventory and test every new point it opened up. The result is a real exposure surface, larger than most healthcare operations can describe accurately today.

A connected medical device isn't just another IoT device

Generic IoT hardware updates with relative freedom. Medical devices don't: the firmware running on them is usually tied to the equipment's regulatory certification, and any software change can trigger a full recertification — an expensive, slow process most manufacturers avoid doing often. The practical result is equipment connected to the network, processing patient data, running firmware that can go years without a security update, by design, not by negligence.

Telehealth APIs multiplied integration points

A telehealth platform rarely operates in isolation — it integrates with insurance authorization, pharmacy dispensing, medical records, payment. Each integration is a new API endpoint, and a good share of those integrations got built under pressure to launch fast, not under the same security testing rigor a financial API would get under direct regulatory requirement.

Inventory is the first bottleneck, not the testing tool

Biomedical engineering usually manages the medical device; IT manages the network and the application. That organizational split — similar to the IT/OT divide we've already covered in the industrial context — creates the same kind of blind spot: nobody, on their own, holds the full inventory of what's connected and exposed. Before any testing tool enters the picture, the operation needs to answer that basic question: how many devices and how many API endpoints actually exist, today, on the network.

Continuous testing, not an annual audit

With device fleet and integrations changing constantly, a one-off annual audit is outdated before it's even finished. Attack surface management with continuous testing, instead of a point-in-time assessment, is the model that actually keeps pace — because it reassesses the surface as it changes, not on a fixed date in the calendar.

A surface that grows fast needs visibility at the same pace

Mapping connected medical devices and telehealth APIs with the same rigor applied to any other critical system isn't optional for a modern healthcare operation. UNIQ helps this kind of operation structure that mapping. Talk to the technical team to understand the real size of your exposure surface.